ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,672, issued on July 29, was assigned to University of Washington (Seattle).

"Compositions and methods for antigen targeting to CD180" was invented by Edward Clark (Seattle) and Jay Wesley Chaplin (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease."

The patent was filed on May 16, 2024, under Application No. 18/665,920.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsea...